An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Drug Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts privately for source information, while also obtaining discount codes.
Active Commerce on Social Networks
Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share comparison images, injection guides and claims of next-day British shipping. Vendors market the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting products of uncertain source.
Several experts said the demand for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.
Service Response and Content Removal
Based on the social media company, the service has removed violative material and banned associated keywords and search suggestions. The organization said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.
Within minutes of joining one community, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Item Information and Pricing
Inside these communities, posts show black plastic parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for the messaging service said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to potentially serious health risks”.
